The global nuclear medicine equipment market size reached US$ 2.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4 Billion by 2027, exhibiting at a CAGR of 6.8% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Nuclear medicine equipment are medical devices that utilize radionuclides or radioactive materials to generate anatomical images and record the progression of diseases. Radionuclides refer to the compounded cleaning molecules with excessive nuclear energy used for producing radiopharmaceuticals. The equipment are utilized for examining various biological processes, such as metabolism, tissue blood flow, functioning of cell receptors, neurotransmitter activity and apoptosis. They utilize specialized gamma cameras and single-photon emission-computed tomography (SPECT) imaging technologies for detecting movement disorders and different types of dementia. As a result, the equipment finds extensive applications for the treatment of various oncological, cardiovascular, gastrointestinal, endocrine and neurological disorders.
Nuclear Medicine Equipment Market Trends:
The increasing prevalence of chronic medical ailments across the globe is one of the key factors creating a positive outlook for the market. Moreover, the rising geriatric population, which is more prone to age-related and associated diseases, is providing a thrust to the market growth. In line with this, the increasing requirement for personalized medicines among healthcare professionals and patients is also contributing to the growth of the market. Various technological advancements, such as the development of data integrated imaging systems and radiotracers, are acting as other growth-inducing factors. These systems enable the reconstruction and processing of computer-assisted images and accurate recognition of medical conditions to compare diagnostic scans and monitor the progression of a disease. Healthcare institutions are also rapidly shifting from standalone to hybrid imaging solutions for generating precise and high-resolution images. Other factors, including extensive research and development (R&D) activities in the field of biotechnology, along with significant improvements in the medical infrastructure, especially in the developing economies, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global nuclear medicine equipment market report, along with forecasts for growth at the global and regional level from 2022-2027. Our report has categorized the market based on product, application and end user.
Breakup by Product:
- Single-Photon Emission Computed Tomography
- Positron Emission Tomography
- Planar Scintigraphy
Breakup by Application:
Breakup by End User:
- Imaging Centers
- Academic and Research Institutes
Breakup by Region:
- North America
- South Korea
- United Kingdom
- Latin America
- Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Biodex Medical Systems Inc. (Mirion Technologies Inc.), Cardinal Health Inc., CMR Naviscan Corporation, DDD-Diagnostic A/S, Digirad Corporation, General Electric Company, Koninklijke Philips N.V., Mediso Ltd., Neusoft Corporation, Siemens AG, SurgicEye GmbH and Toshiba Corporation.
|Base Year of the Analysis
| Historical Period
||Product, Application, End User, Region
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||Biodex Medical Systems Inc. (Mirion Technologies Inc.), Cardinal Health Inc., CMR Naviscan Corporation, DDD-Diagnostic A/S, Digirad Corporation, General Electric Company, Koninklijke Philips N.V., Mediso Ltd., Neusoft Corporation, Siemens AG, SurgicEye GmbH and Toshiba Corporation
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report:
- How has the global nuclear medicine equipment market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global nuclear medicine equipment market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global nuclear medicine equipment market and who are the key players?
- What is the degree of competition in the industry?